Related Experiment Videos
Radiation abscopal antitumor effect is mediated through p53.
Kevin Camphausen1, Marsha A Moses, Cynthia Ménard
1Radiation Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
Cancer Research
|April 19, 2003
Summary
The abscopal effect, where radiation shrinks distant tumors, is mediated by p53. This tumor suppression is radiation dose-dependent and requires functional p53 pathways.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- The abscopal effect describes an antitumor response in non-irradiated sites following localized radiation therapy.
- The precise mechanisms underlying the abscopal effect remain incompletely understood.
- The tumor suppressor protein p53 is known to be upregulated in response to radiation.
Purpose of the Study:
- To investigate the role of p53 in mediating the abscopal effect.
- To determine if the abscopal effect is tumor-specific.
- To assess the radiation dose dependency of the abscopal effect.
Main Methods:
- Irradiation of non-tumor-bearing legs in wild-type p53 and p53-null mice bearing distant Lewis lung carcinoma (LLC) or T241 fibrosarcoma.
- Evaluation of tumor growth rates in response to varying radiation doses and p53 inhibition (pifithrin-alpha).
Main Results:
- Localized leg irradiation significantly inhibited distant LLC and T241 tumor growth in wild-type p53 mice, but not in p53-null mice or when p53 was blocked.
- The abscopal effect demonstrated a radiation dose dependency, with reduced inhibition at lower doses.
- The findings suggest the abscopal effect is not tumor-specific.
Conclusions:
- The protein p53 is a critical mediator of the radiation-induced abscopal effect.
- Downstream signaling pathways of p53 are essential for eliciting the abscopal response.
- Targeting p53 pathways may offer novel therapeutic strategies for enhancing abscopal effects in cancer treatment.